Medicare will begin covering GLP-1 medications for obesity through the Medicare GLP-1 Bridge program starting July 1, 2026, offering eligible beneficiaries access for $50 per month
Myrosinase catalyzes the hydrolysis of endogenous glucosinolates into biologically active goitrogenic compounds, including thiocyanates and nitriles, potentially resulting in goiter and hypothyroidism
GLP-1s: The Second Serving Revisiting our GLP-1 Basket In case you missed it, our new portal allowing real-time tracking and performance on every thematic basket we cover and our model portfolio recently went live at citrindex.com Introduction Two years ago, CitriniResearchs third-ever thematic primer Upgrading from Overweight made a host of bold claims about the new class of weight loss drugs, GLP-1s
The curve climbs faster because you are adding a larger dose on top of an already-established baseline
B12 deficiency anemia is tough to diagnose because it doesnt always present with apparent symptoms
Patients who tense their muscles in anticipation of the injection often experience more discomfort than those who remain relaxed
